Skip to content

Released May 8, 2020, before the open

10-Q filed May 8, 2020, 38 days after period end · 0001564590-20-023255

Q1 2020 · 10-Q
Revenue$104.82M−3.9% vs Q1 2019−13.7% vs Q4 2019
Net Income$25.67M+2,761.2% vs Q1 2019+119.6% vs Q4 2019
EPS Diluted$1.32+2,540.0% vs Q1 2019+120.0% vs Q4 2019
Gross Profit$81,414,000−4.7%
Operating Income$6,854,000N/M
Operating Cash Flow$12,464,000N/M
Free Cash Flowderived$8,179,000N/M
Margins · derived
Gross margin77.7%−0.6 pt vs Q1 2019
Operating margin6.5%+10.6 pt vs Q1 2019
Net margin24.5%+23.7 pt vs Q1 2019

What the release said

The release

Same quarter

MetricQ1 2020Q1 2019Q1 2018Q1 2017
Revenue$104.82M$109.11M$108.71M$102.74M
Net Income$25.67M$897.00K$5.23M-$2.65M
EPS Diluted$1.32$0.05$0.27-$0.15

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR